Smart Immune, a clinical-stage biotechnology company, has recently achieved a major breakthrough by developing an innovative bioproduction method for cultivating T-cell progenitors. Smart Immune is now seeking a Chimeric Antigen Receptor (CAR) construct, that enables precise recognition of tumour antigens, to develop a groundbreaking CAR-T Cell therapy for the treatment of haematological and/or solid tumour malignancies.
Approaches of Interest:
- All mechanisms of action relating to CARs within the oncology field are of interest
- Both conventional CARs (including...
' style='fill: %23646464'/%3E%3Cpath d='M63.033,42.5693,68.794,4.3872h6.857l5.7647,38.1822H75.9639l-1.0334-7.796H69.53l-1.0488,7.796Zm9.5025-25.7679-.1562-.9861H72.066l-.1566.9861L70.2987,28.8479h3.8492Z' transform='translate(-4.7634 -4.3871)' style='fill: %23646464'/%3E%3Cpath d='M94.0445,42.5694,91.1326,26.4605H89.63V42.5694H84.01V4.3871h5.62c6.638,0,9.55,3.8432,9.55,11.0134,0,3.7884-.9864,7.2168-3.1155,8.6728l3.5853,18.4962ZM89.63,9.9447V21.271c1.55,0,4.1486-.2115,4.1486-5.667,0-5.4483-2.5989-5.6593-4.1486-5.6593' transform='translate(-4.7634 -4.3871)' style='fill: %23646464'/%3E%3Cpolygon points='96.027 5.769 96.027 0 112.23 0 112.23 5.769 106.934 5.769 106.934 38.182 101.319 38.182 101.319 5.769 96.027 5.769' style='fill: %23646464'/%3E%3C/g%3E%3Crect y='43.3662' width='38.1352' height='7.635' style='fill: %239ccae2'/%3E%3Crect x='38.1352' y='43.3662' width='38.1427' height='7.635' style='fill: %23c3e483'/%3E%3Crect x='76.2779' y='43.3662' width='38.1336' height='7.635' style='fill: %23f7a95f'/%3E%3C/g%3E%3C/g%3E%3C/svg%3E)